ActoGeniX's Series B Round

ActoGeniX raised a round of funding on January 01, 2009.

ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs; ActoBiotics. ActoGeniX's mission is to develop and commercialize inn…

Articles about ActoGeniX's Series B Round: